CD274 and neoplasm: Studies examining possible predictive biomarkers of response to immunotherapy have reported a higher density of preexisting cytotoxic T lymphocytes in tumor biopsies of patients who displayed a greater response to anti-PD-1/PD-L1 immunotherapy, and more significantly, an increased influx of T cells and PD-L1 macrophages early during treatment.